Basit öğe kaydını göster

dc.contributor.authorUçar, Murat
dc.contributor.authorSoyupek, Sedat
dc.contributor.authorOksay, Taylan
dc.contributor.authorÖzorak, Alper
dc.contributor.authorAkkoç, Ali
dc.contributor.authorTopçuoğlu, Murat
dc.contributor.authorKoşar, Alim
dc.date.accessioned2021-02-19T21:16:40Z
dc.date.available2021-02-19T21:16:40Z
dc.date.issued2019
dc.identifier.issn0148-5598
dc.identifier.issn1573-689X
dc.identifier.urihttps://doi.org/10.1007/s10916-019-1491-2
dc.identifier.urihttps://hdl.handle.net/20.500.12868/515
dc.descriptionWOS: 000513496500002en_US
dc.descriptionPubMed: 31823081en_US
dc.description.abstractWe aim to investigate the prognostic significance of the hemoglobin X lymphocyte / neutrophil ratio (HLNR) and hemoglobin x lymphocyte / platelet ratio (HLPR) with tumor aggressivity in patients with renal cell carcinoma. We retrospectively analyzed 127 patients' data who had diagnosed as renal cell carcinoma between 2008 and 2019 in Suleyman Demirel University Hospital. Tumor and patient characteristics, hemoglobin, neutrophil, lymphocyte, platelet values HLNR and HLPR were calculated in preoperative hemogram parameters. The relationship between tumor pathological stage, Fuhrman nuclear grade and tumor necrosis with HLPR and HLNR analyzed with statistically. There was a negative correlation between pathologic stage, Fuhrman nuclear grade and tumor necrosis with HLNR. P values are 0.003, 0.012 and 0.015 respectively. HLNR was lower in patients with high pathologic stage, high Fuhrman nuclear grade and accompanying tumor necrosis positiveness. There was a negative correlation between pathologic stage, Fuhrman nuclear grade and tumor necrosis with HLPR. P values are 0.001, 0.014 and 0.047 respectively. HLPR was lower in patients with high pathologic stage, high Fuhrman nuclear grade and accompanying tumor necrosis positiveness. High pathological stage, high Fuhrman nuclear grade and existence of tumor necrosis are associates with preoperative low HLNR and low HLPR in renal cell carcinoma patients. They can be used as prognostic markers in patients with renal mass preoperatively.en_US
dc.language.isoengen_US
dc.publisherSpringeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectKidneyen_US
dc.subjectCarcinoma renal cellen_US
dc.subjectHematologic testsen_US
dc.subjectPrognosisen_US
dc.titleCan we predict preoperative tumor aggressivity with hemogram parameters in renal cell carcinoma? a novel calculation methoden_US
dc.typearticleen_US
dc.contributor.departmentALKÜen_US
dc.contributor.institutionauthor0-belirlenecek
dc.identifier.doi10.1007/s10916-019-1491-2
dc.identifier.volume44en_US
dc.identifier.issue1en_US
dc.relation.journalJournal of Medical Systemsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster